Based on the findings of our study and supporting evidence from the literature, we propose that all patients newly diagnosed with AIH be screened for anti-HBc IgG, HBsAg, and anti-HBs, with HBV-DNA testing in anti-HBc-positive individuals. This evidence concerns the gene KRT88P and autoimmune hepatitis.